Showing results (261-270 of 861) with videos related to

Sort By:
Pageof 87
Neurology|February 12, 2016
Recommendations for observational studies of comorbidity in multiple sclerosisRuth Ann Marrie, Aaron Miller, Maria Pia Sormani, et al.
Biomedicines|December 24, 2021
Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-AnalysisMoritz Förster, Christopher Nelke, Saskia Räuber, et al.
CNS Spectrums|April 11, 2019
Left rostrolateral prefrontal cortex lesions reduce suicidal ideation in penetrating traumatic brain injuryMatteo Pardini, Jordan Grafman, Vanessa Raymont, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2006
Human fronto-mesolimbic networks guide decisions about charitable donationJorge Moll, Frank Krueger, Roland Zahn, et al.
Retina (Philadelphia, Pa.)|November 2, 2016
OPTICAL COHERENCE TOMOGRAPHY AND INFRARED IMAGES OF ASTROCYTIC HAMARTOMAS NOT REVEALED BY FUNDUSCOPY IN TUBEROUS SCLEROSIS COMPLEXMaria G Mutolo, Sara Marciano, Francesca Benassi, et al.
JAMA Neurology|October 13, 2015
Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical TrialJeffrey Cohen, Anna Belova, Krzysztof Selmaj, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 10, 2025
Social determinants of health in multiple sclerosis in Italy: A scoping reviewMarta Ponzano, Maurizio Mario Fedriga, Alessio Signori, et al.
BMC Geriatrics|March 11, 2025
Barriers for access and utilization of dementia care services in Europe: a systematic reviewMichele Sorrentino, Claudio Fiorilla, Michelangelo Mercogliano, et al.
JAMA Neurology|October 2, 2023
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic ReviewJannis Müller, Alessandro Cagol, Johannes Lorscheider, et al.
Clinical Therapeutics|August 22, 2012
Long-term cost-effectiveness model of interferon beta-1b in the early treatment of multiple sclerosis in the United StatesFeng Pan, Jo Wern Goh, Gary Cutter, et al.
Pageof 87